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Part 2 of this narrative review outlines the theoretical and practical bases for assessing the efficacy 
and effectiveness of conventional medicines and homeopathic products. Known and postulated 
mechanisms of action are critically reviewed. The evidence for clinical efficacy of products in both 
categories, in the form of practitioner experience, meta-analysis and systematic reviews of clinical 
trial results, is discussed. The review also addresses problems and pitfalls in assessing data, and 
the ethical and negative aspects of pharmacology and homeopathy in veterinary medicine.
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Assessment of efficacy
In medicine and therapeutics, treatments can be evaluated in terms 
of two differing but complementary scientific frameworks. The 
empiricist framework assesses whether the treatment actually works 
in animals or people; that is, it has ‘clinical efficacy’ in the form of 
a beneficial therapeutic effect measurable in laboratory animals or 
clinical trials. The reductionist framework assesses how the treatment 
works – investigating the mechanism of action at a submolecular, 
molecular, cell, tissue/organ and/or system levels as tested in vitro, ex 
vivo or in vivo studies – determining whether the treatment exerts 
effects at these levels that can give rise to a clinical therapeutic effect. 
A distinction should also be made between clinical ‘efficacy’ and 
‘effectiveness’. Efficacy comprises performance of a drug under ideal, 
controlled circumstances. Effectiveness, on the other hand, constitutes 
performance under ‘real-world’ conditions. Thus, clinical efficacy 
answers the question ‘does it work in clinical trials’ while clinical 
effectiveness addresses the question ‘does it actually benefit patients 
in practice’ (Godwin and others 2003, Gartlehner and others 2006).
In the whole animal, studies may be conducted in healthy ani-
mals, in disease models or in clinical subjects. For every level of testing, 
controls and statistical analysis should be applied, as appropriate. This 
approach is the basis of modern science-based medicine. Wherever 
possible, a product will be tested for clinical efficacy and/or effective-
ness in randomised, double-blinded, placebo-controlled trials; these 
provide the best evidence for the practice of evidence-based veterinary 
medicine (EBVM), which consists of the application of the best avail-
able evidence to practice (Sackett and others 1996). Assessment of 
clinical efficacy and effectiveness should be based on scientific analy-
sis of data rather than relying on the observations and experiences of 
practitioners in carrying out their routine duties, because the latter is 
Review
unreliable (Kohn and others 2000, Shojania 2003, Doust and Del Mar 
2004, Hartman 2009, Oxtoby and others 2015, Prasad and Cifu 2015, 
Saposnik and others 2016).
These approaches have provided good evidence of efficacy and/
or effectiveness and/or proven or plausible underlying mechanisms 
of action for most conventional drug-based products, especially of 
the more commonly used medicines; particularly in the human field, 
in which products are tested far more than in veterinary medicine. 
In contrast, as discussed below, attempts to demonstrate biological, 
clinically relevant effects of homeopathic products in vitro have not 
shown any clear successes, and the highest quality clinical trial evi-
dence has failed to show convincing evidence of efficacy of homeo-
pathic remedies (Shang and others 2005, Mathie and Clausen 2014, 
Mathie and others 2014). From a scientific viewpoint, this is unsur-
prising given that homeopathic remedies commonly contain little or 
no ‘active’ ingredient, implying that homeopathic remedies do not 
exert effects via physiological/biochemical mechanisms that can be 
scientifically measured.
Yet homeopaths in practice insist their treatments are effective (for 
example, Kayne 2006, Mathie and others 2007, 2010, Gregory 2008, 
2013a, Reilly 2008a, British Association of Homeopathic Veterinary 
Surgeons 2017, British Homeopathic Association 2017). As discussed 
in part 1 of this review (Lees and others 2017), homeopathic belief 
proposes – and, importantly, homeopathic practice implies – that 
during preparation of a remedy, the ‘active’ ingredient imparts an 
unknown curative property to the remedy. This is presumably by 
transference of this property to the diluent or by a transformation of 
the diluent, because the curative property persists, and is most potent, 
in highly diluted remedies containing no molecules of the starting sub-
stance. This curative property, latent in the starting substance, is made 
active (‘dynamised’ or ‘potentised’ in homeopathic terminology) by 
repeated, serial dilution and succussion (a specific type of agitation 
of the remedy). The more dilution and succussion, the more potent 
the healing power of the remedy. In the belief system of homeopathy, 
this curative property is thought to be an ‘energy’, specifically a ‘life 
energy’ or ‘vital force’ (for example, Kayne 2006, Nicolai 2008, Owen 
2015d), that is often described as ‘vibratory’ and ‘resonant’. However, 
homeopaths are unable to demonstrate this hypothetical ‘energy’ 
(vide infra). In the belief system of homeopathy, remedies work in 
a wholly different manner to conventional drugs, frequently stated 
to consist of an unspecified ‘balancing’ of undefined ‘energies’ (the 
‘vital force’) in the body (Bell and others 2004, Kayne 2006). Thus, 
the fact that there appears to be no scientifically conceivable way in 
which homeopathic products could act on biochemical pathways 
or physiologic processes underlying the diseases they treat is not an 
impediment to their practice. The question to be posed is, can and 
should homeopathy be evaluated using the same preclinical and clini-
cal methods and standards as for conventional drugs?
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Theoretical and actual bases for efficacy 
Homeopathy
From a scientific, material perspective, homeopathic remedies are 
physical entities, comprising vast numbers of molecules of diluent 
– usually water and/or alcohol – with the only other components 
being: many, few or no molecules of the ‘active’, dependent on the 
degree of dilution; and any contaminants. Some remedies contain 
other deliberate additives, such as sugar, but such additives are gener-
ally not claimed to contribute directly to the alleged healing effects 
(Kayne 2006). These liquid remedies may be mixed with or dropped 
or sprayed onto other pharmaceutical preparations to create homeo-
pathic creams, ointments, pills and powders.
Molecules of the ‘active’
Each batch of product, depending on the degree of dilution, might 
contain many, few or no molecules of the starting substance or 
‘active’; for dilutions beyond the Avogadro limit (1x10-24, expressed 
in homeopathic notation as ‘12c’) there should be no molecules of the 
‘active’ in the remedy (Kayne 2006). Homeopathic belief and practice 
implies that for any one remedy, the presence or absence of molecules of 
the starting substance, or the precise number of such molecules present, 
is inconsequential for its medicinal effect. This must be the case, 
because: homeopaths do not usually claim that the starting substances 
per se can exert the medicinal effects of the ‘potentised’ remedies 
produced from them; at the lower dilutions – those not beyond the 
Avogadro limit – the ‘potency’ of the remedy increases with dilution, 
it is negatively correlated with the number of molecules of ‘active’ 
present; homeopaths very commonly use remedies diluted beyond the 
Avogadro limit, and claim that: such ultra-diluted remedies containing 
no molecules of the starting substance are not only effective, but more 
effective than less diluted remedies; and that increasing dilution of 
the remedies increases their effectiveness, even at dilutions where no 
molecules of the starting substance remain (for example, Hahnemann 
2002, Kayne 2006, 2008). 
For the great majority of substances from which homeopath-
ic products are made, the starting material per se is not claimed to 
exert the healing effect of the remedy produced from it. Therefore, 
the ‘curative property’ must be latent in the starting substance, and 
is passed into the remedy during the preparation process, starting 
with – depending on the nature of the substance or thing – dissolving, 
grinding-up, soaking or percolating it in water and/or alcohol (Kayne 
2006). This curative property then has to be activated (‘dynamised’, 
‘potentised’ or ‘energised’) by serially diluting and succussing the solu-
tion or suspension (the ‘mother tincture’) so obtained (Kayne 2006). 
Thus, eating onion does not cure a common cold but, homeopaths 
claim, taking the remedy Allium cepa, prepared by grinding up onion in 
diluent and then serially diluting and succussing the mother tincture 
until there are few or no molecules of the onion in the remedy, can 
cure signs and symptoms of a cold (Boericke 2008).
What property of the starting substance brings about the alleged 
healing effect is not known. However, by simple reasoning, if it is not 
molecules of the substance, then either some other property of the 
substance is transferred to the water/alcohol, or the substance must 
bring about some transformation of the water/alcohol itself. It is that 
unknown transferred property or transformation of the water/alcohol 
that must provide the alleged healing effect, once it has been further 
enhanced with each round of dilution and succussion. As noted above, 
this unknown property is often referred to by homeopaths as an ‘ener-
gy’ and, in homeopathic belief, as manifestation of a ‘vital force’.
Cowan and others (2005) found that water in the liquid state is 
highly efficient at redistributing its hydrogen bonds with a ‘memory’ 
of less than 50 femtoseconds (<5x10-14 s). Water ‘memory’, of the 
nature and duration required to comprise a mechanism of action of 
homeopathic products – to transfer information from the starting sub-
stance to the patient who takes the remedy – is not known to physi-
cal, chemical and biological sciences. Consistent with this observa-
tion, studies of remedies diluted far beyond the Avogadro limit (ie, that 
would not be expected to contain even one molecule of the ‘active’), 
including comparisons with control solutions not produced from an 
‘active’, have failed to provide any convincing, independently repli-
cated demonstration of any special physical or chemical property of 
the remedies (Aabel and others 2001, Milgrom and others 2001, Rey 
2003, 2007, Roy and others 2005, Elia and others 2006, van Wijk 
and others 2006, Rao and others 2007, Cartwright 2016). Aabel 
and others (2001) and Milgrom and others (2001) failed to replicate 
results from previous nuclear magnetic resonance measurements of 
homeopathic remedies, and concluded that there was no difference 
between homeopathic and control solutions. Examples of reported 
differences awaiting replication include Rey (2003, 2007), who meas-
ured low-temperature thermoluminescence, and Cartwright (2016), 
who used solvatochromic dyes. These reports are typical of these 
types of studies in that they involved technically complex analytical 
methods and lacked important control measures and other safeguards 
against error, for example, in neither was the experimenter ‘blinded’ 
and in Cartwright (2016) the control solution was not repeatedly 
diluted and succussed as the remedy was. The use of complex meth-
ods in the absence of control measures predisposes to false-positive 
findings, especially if the experiments were carried out by believers 
in homeopathy, and such false-positive findings may be more likely 
to be published by journals specifically concerned with homeopathy 
or other complementary and alternative therapies, if the journal edi-
tors and peer reviewers do not fully understand the methodology (Lee 
and others 2002, Smith 2006, Doehring and Sundrum 2016). Such 
factors are why independent replication is so important – not just for 
homeopathy-related experiments, but for any new experimental result 
(Ioannidis 2005a, Prasad and Cifu 2015). Further, it is notable that, for 
the phenomena so far reported in such studies, there is no indication 
of how the phenomena – if genuine – might contribute to the claimed 
medicinal effects of the remedies. 
Montagnier and others (2009) claimed to find electromagnetic 
signals from bacterial deoxyribonucleic acid in extreme dilutions. 
However, from a physical and technical perspective, this work is suspect 
(Grimes 2012) and this finding has not been independently replicated.
We note that the curative property must interact with the physical 
world in order to: pass from the starting material into a remedy; pass 
from dilution to dilution; increase in potency as a result of succussion; 
and cure diseases in a patient. Therefore, if this curative property exists, 
the failure of modern science to detect any trace of it in remedies appears 
astonishing. Any genuine difference between ultra-dilute remedies, or 
between such a remedy and its diluted diluent-only control, would be a 
fundamentally revolutionary finding for the fields of physics and chem-
istry in general. And if the curative property was found to be able to 
treat almost any disease of a huge range of aetiologies and pathogen-
eses – infectious, inflammatory, toxic, neoplastic, structural, congenital 
– that would be a fundamentally revolutionary finding for the fields of 
biology and medicine. However, there is no proven, replicable difference 
between ultra-dilute homeopathic remedies and control solutions made 
from the same diluent to explain the alleged curative actions of homeo-
pathic remedies, and the ‘potentised’ curative property in homeopathic 
products remains undetected by modern science.
Numerous studies claim to show that homeopathic remedies have 
effects on in vitro cell preparations or experimental animal models 
(many such studies are listed by Malik 2012, and Rational Veterinary 
Medicine 2017). These studies typically show the same types of 
design weaknesses as those searching for special physical and chemi-
cal properties of the remedies themselves, and are without independ-
ent replication to confirm the effects reported. There have been some 
‘false alarms’, but none have been convincingly replicated. Possibly 
the best known case was a paper published in Nature (Davenas and 
others 1988) in which the eminent immunologist Benveniste’s 
research group claimed that human basophils produced histamine 
when exposed to anti-immunoglobulin E even at a dilution of 60c. 
The findings were later shown to be due to observer bias (Maddox and 
others 1988). The data had been generated by an unblinded technician 
and subsequent multiple attempts by independent researchers to rep-
licate the findings failed (Maddox and others 1988, Hirst and others 
1993). Benveniste continued to claim that the results were authentic 
(Kayne 2006) and, later, that he could encode the effect electronically 
and transmit it over telephone lines, to turn water into a homeopathic 
remedy remotely (Jonas and others 2006). Belon and others (2004) 
and Ennis (2010) concluded that ultra-dilute histamine solutions may 
modulate basophil activation; but the effect was small and inconsist-
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ent. It was further concluded that well-controlled, large-scale studies 
are required to confirm the small and inconsistent effect. These have 
not been forthcoming.
Contaminants
In the preparation of homeopathic remedies the starting ‘active’ is 
rarely a pure or sterile substance, and so will be contaminated with 
a variety of inorganic and organic chemicals and microorganisms, 
but homeopaths regard these as being a natural part of the ‘active’ 
(Kayne 2006), presumably conceived as contributing to the curative 
property in the remedy. Water inevitably contains many other 
compounds, including dissolved gases (nitrogen, oxygen, carbon 
dioxide and others), inorganic chemicals (sodium, chloride, calcium, 
phosphate), organic molecules from animal and vegetable sources, 
and possibly living microorganisms as sterility is not generally 
claimed for homeopathic products. Many homeopathic remedies are 
prepared using distilled water, which will eliminate or reduce some 
of these contaminants. In general, homeopaths do not appear to 
regard contaminants in the diluent as contributing to their remedies’ 
medicinal effects, even though any contaminants present in early 
dilutions would presumably be ‘potentised’ by the later dilutions 
and succussions. However, there is a class of contaminants that some 
homeopaths (Anick and Ives 2007, Bell and Koithan 2012, Bell 
and others 2015) have speculated may provide a mechanism for the 
action of remedies diluted beyond the Avogadro limit – nanoparticles 
either of the ‘active’ and/or of silica from the glass vials in which 
the remedies are diluted and succussed. Molecules of the starting 
substance, in the form of nanoparticles, have been found in some 
Indian commercial ultra-high dilution (30c and 200c) remedies made 
from metals (Chikramane and others 2010, Temgire and others 
2016). The presence of such nanoparticles presumably constitutes 
either incomplete dilution or contamination by some of the starting 
substance after dilution. Bell and Koithan (2012) and Bell and others 
(2015) speculated that nanoparticle contaminants in homeopathic 
remedies could constitute a mechanism for transfer of information 
via ultra-dilute remedies from the starting substance to the patient, 
but have provided no evidence that it does so.
Selection of homeopathic remedies
In homeopathic practice, remedies are selected on the basis of 
patients’ symptoms and signs (signs only in animals), and on other 
characteristics of patients such as their temperament, preferences in 
life or previous experiences (Gregory 2008, Lilley 2008, Nicolai 2008, 
Reilly 2008, Owen 2015a, b, c, British Association of Homeopathic 
Veterinary Surgeons 2017). The overall ‘symptom picture’ of the 
patient is matched as closely as possible to the ‘symptom picture’ 
for the remedy, which is the collection of signs and symptoms that 
the remedy is believed to the able to treat, as listed in homeopathic 
Materia Medica (Owen 2015a, b, c). This is the practical application 
of the principal that ‘like-cures-like’ – that signs and symptoms can be 
cured by a remedy prepared from a substance that caused those signs or 
symptoms in healthy individuals. The ‘symptom picture’ for a remedy 
is primarily determined by a homeopathic ‘proving’ in which healthy 
volunteers take the substance or, more commonly, a remedy prepared 
from that substance, and then record their thoughts, feelings and signs 
(Hahnemann 2002, Kayne 2006, Lilley 2008, Riley 2008, Sherr 2015). 
Most provings are conducted using an ultra-dilute remedy, not 
the undiluted starting material. Some remedies appear to have never 
been subject to ‘provings’, including some of the common homeo-
pathic remedies (Campbell 2013), and toxicological observations or 
‘therapeutic responses’ also contribute all or part of the ‘symptom pic-
ture’ for some remedies (Belon 1995, Kayne 2006, Campbell 2013). 
Importantly, the ‘symptom picture’ does not just consist of the symp-
toms and signs associated with the illness the patient may have, but 
includes other characteristics of the patient; for example, their tem-
perament, preferences in life, or previous experiences, most of which 
conventional medicine would regard as incidental to the illness being 
treated (Gregory 2008, Lilley 2008, Nicolai 2008, Reilly 2008, Owen 
2015a, b, c, British Association of Homeopathic Veterinary Surgeons 
2017). For this reason, identical symptoms and signs of illness may be 
treated with different remedies in different subjects. The inclusion of 
these other factors in choice of remedy is a large part of what homeo-
paths mean when they refer to their therapy as being ‘holistic’; that 
is, treating the whole individual, but from a conventional medicine 
viewpoint this simply introduces a further degree of arbitrariness into 
the selection of remedies. From a scientific perspective, there seems 
to be no reason why ‘like’ should cure ‘like’ and the very concept of 
treating an illness with a substance (yet alone a highly-diluted remedy 
made from that substance) that reportedly created similar signs and 
symptoms in healthy volunteers appears arbitrary.
From the above considerations, it is clear that any mechanism by 
which homeopathic remedies act must differ fundamentally, not only 
from the fundamental principles of pharmacology, but also from the 
mechanisms of action of endogenous chemicals, such as hormones 
and neurotransmitters – their action cannot be based on conventional 
mechanisms of biochemistry and physiology, either in the patients’ 
body or in disease causing organisms. 
Pharmacology
When drugs are used therapeutically, they may treat either the 
underlying cause of disease/malfunction or the symptoms or signs 
(signs only for animals) of disease. The armamentarium consists of 
widely diverse classes of drugs, each with discrete mechanisms of 
action and targeting specific biochemical pathways in the body or in/
on a disease-causing organism. Thus, antimicrobials, anthelmintics, 
anaesthetics, analgesics and hormones all work in fundamentally 
the same way (molecule to molecule interaction) but on differing 
biochemical pathways. Even within a general group, such as 
analgesics or antibiotics, the biochemical pathways differ for each 
subclass of agent. In contrast, in the homeopathic belief system, 
all remedies appear to be conceived of as acting via a single process 
that, as discussed above, is typically described in terms of balancing 
‘energies’ or restoring ‘vital force’.
The properties of drugs and the science underpinning their use 
have been described in innumerable peer reviewed publications, the rate 
of which has accelerated in recent years. Counting only those drug-
based papers classified as pharmacological, the numbers identified in 
Web of Knowledge were 167 in 1950, 44,426 in 1980 and 90,931 in 
2010. Of these, the number (and percentage of the total) classified as 
veterinary pharmacology were 0 (0 per cent), 282 (0.635 per cent) and 
3630 (3.992 per cent) (Lees and others 2013, Toutain and others 2016b).
Flower (2013) reviewed the basic principles of pharmacology; for 
reviews of veterinary aspects, see Anon (2004) and Cunningham and 
others (2010). The two pillars of pharmacology are pharmacodynam-
ics and pharmacokinetics. 
Pharmacodynamics is the science of drug action on the body 
or on a parasite/microorganism on or in the body; it is based on 
the concept that drug molecules interact with cellular molecules. 
Pharmacodynamics is studied qualitatively and quantitatively at sub-
molecular, molecular, organelle, cell, organ/tissue and whole animal 
levels. Drugs act in the same manner as hormones, neurotransmit-
ters and autacoids (local hormones) on receptors or enzymes, either 
to stimulate (an agonist) or to block (an antagonist) them or, for a few 
drugs, to do both (partial agonists).
The key pharmacodynamic properties of all drugs are: efficacy – 
this includes effectiveness, action on the receptor, ability to produce 
a response and the magnitude of the response attainable; potency – 
amount of drug required to produce an agonist or antagonist response, 
usually measured as EC50 or IC50 (50 per cent of maximum attain-
able excitatory or inhibitory responses, respectively); and sensitivity 
– the steepness of the relationship between concentration or dose and 
response. In the laboratory, the drug-response relationship is usually 
quantified in concentration/effect terms; in the animal it is usually 
monitored as dosage versus effect. For a large majority of drug/recep-
tor interactions, the log of concentration relates to arithmetic response 
in a sigmoidal manner (a monotonic relationship), and there is usually 
a threshold concentration, below which no effects occur – even the 
threshold concentration typically being far higher than the concentra-
tion of the ‘active’ present in most homeopathic products – and the 
dose-response curve showing increasing effect with concentration; 
that is, the opposite of the concentration/effect relationship claimed 
for homeopathic products. 
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For some drug actions, the dose-response relationship is not S 
shaped; but inverted U or J shaped (Calabrese and Baldwin 2001, 
Calabrese 2005). Vandenberg (2014) described non-monotonic dose/
response curves (NMDRCs) for natural hormones and endocrine dis-
rupting chemicals (EDCs) in biological systems, including cultured cells, 
whole organ cultures, laboratory animals and human populations. She 
provided evidence for NMDRCs in the EDC literature, specifically for 
bisphenol A, and questions the current risk assessment practice where 
‘safe’ low doses are predicted from high dose exposures. It has been 
suggested (Bellavite and others 2010, Calabrese and Jonas 2010) that 
this phenomenon of hormesis – a dose response phenomenon charac-
terised by a reversal of response with concentration, resulting in either 
a J shaped or an inverted U shaped dose response curve such that a 
response may increase with dilution over a limited range at low con-
centrations – provides plausibility to homeopathy. However, none of 
the examples of hormesis go beyond or even near the Avogadro limit. 
Moreover, the magnitude of hormetic effects is small (Calabrese and 
Baldwin 2002) and hormesis occurs over a very limited range of con-
centrations (Calabrese and Baldwin 2002); in most cases the reversal of 
the effect with increasing concentration occurs over less than a 10-fold 
range (corresponding to the smallest unit of dilution, 1x, of homeo-
pathic remedies) and hormesis rarely extends over two orders of magni-
tude (corresponding to a 1c homeopathic dilution), let alone the many 
orders of magnitude over which homeopathic products are alleged to 
become more potent with increasing dilution. In addition, the shape 
of the dose response curve differs from that of the monotonic nega-
tive ‘dose-response’ relationship claimed for homeopathic remedies. 
Finally, hormesis is a spontaneous natural phenomenon, which does 
not require homeopathic ‘potentisation’ in order to occur.
It could be argued that conventional vaccines are ‘homeopathic’ 
because they are made from something that can create, in healthy indi-
viduals, signs and symptoms of the disease the vaccines are used to 
prevent. However, vaccines are not like the thing they are used to pre-
vent, they are the very thing (or a part of, or a modified version of, the 
thing) they aim to prevent. Vaccines work in a well-characterised, sci-
entifically plausible way, by presenting antigens to the body’s immune 
system. Homeopathic remedies, including the nosodes (Kayne 2006) 
that are the homeopathic (strictly ‘isopathic’ as they are made from 
something considered to be involved in causing the illness, for exam-
ple, a mosquito may be used to make a nosode to prevent malaria) 
alternative to vaccines, do not employ that mechanism. Conventional 
vaccines may contain relatively small amounts of the antigen, but it 
is still very much greater than the Avogadro limit, and they are not 
efficacious if diluted below a certain threshold. These properties make 
conventional vaccines entirely different to homeopathic remedies.
Pharmacokinetics is the science of drug absorption into, and fate 
within, the body. It encompasses dissolution, absorption, distribution 
and elimination processes, the latter comprising biotransformation 
(metabolism) and excretion pathways. Biotransformation involves 
principally the liver but other organs, such as the kidney and lung, 
may also contribute. Moreover, metabolism normally renders drugs 
less active or inactive but, in the case of prodrugs, biotransformation 
provides or enhances activity. Excretion involves, for most drugs, renal 
and/or hepatic pathways (ie, elimination in urine or secretion into bile, 
respectively). In ruminants, drug elimination in milk is significant for 
establishing a withholding time in relation to human consumption. 
These pharmacokinetic processes have been studied extensively, 
both quantitatively and qualitatively. Pharmacokinetic processes, 
which have been defined and quantified for a wide range of drugs 
in a wide range of species, include clearance, absorption half-life, 
elimination half-life, volumes of distribution (central, area and steady 
state) and bioavailability (percentage of administered dose absorbed 
systemically). As well as inevitable intra-animal (eg, day-to-day) vari-
ation and intra-species (eg, dog to dog) differences, many profound 
inter-species differences (eg, dog to cat) in pharmacokinetic profiles 
exist. Moreover, there is increasing evidence of pharmacokinetic 
dependency on factors, such as age, breed, size and health status. For 
example, population pharmacokinetics quantifies breed differences, 
together with those associated with diseased compared to healthy ani-
mals. Indeed, for one drug, celecoxib, within breed differences were 
reported in healthy beagle dogs; fast and slow metabolisers within the 
single breed were identified (Paulson and others 1999). For another 
drug of the same class, mavacoxib, pharmacokinetic differences have 
been defined between small and larger breeds in the clinical popula-
tion (Lees and others 2015a). 
By quantifying the contribution of these factors to variability, 
and by linking pharmacodynamics with pharmacokinetic proper-
ties, a rational basis for designing dose schedules for use in the clinical 
population, is provided. This approach has been used to predict target 
attainment rate doses of antimicrobial drugs for a given level of bacte-
rial kill (say 99.9 per cent) in a given percentage of the clinical popula-
tion (say 50 or 90 per cent) (Lees and others 2015b).
In contrast, there appears to be no equivalent of pharmacokinet-
ics in homeopathy; because the ‘curative property’ of homeopathic 
remedies is undetectable, it is not possible to measure whether it varies 
with location in the body, or over time, and so equivalents of parame-
ters and variables such as bioavailability, half-life and clearance cannot 
be determined. For this reason, the posology of homeopathic rem-
edies – the ‘potency’ used, frequency of administration and duration 
of treatment, must be entirely empirical, if not arbitrary. Kayne (2006) 
and Nicolai (2008) discuss homeopathic posology in human patients. 
Gregory (2008) observed that animals appear to need more doses of 
homeopathic remedies than humans, that the smaller species need 
much more frequent dosing, and that horses are far more sensitive to 
homeopathic remedies than any other species. 
Problems and pitfalls in assessing data
Irrespective of the differing proposed mechanisms of action of 
homeopathic and drug-based products, the means of assessing clinical 
efficacy and effectiveness should be applicable to both. These should 
include the experience of clinicians in their daily practice, as well as 
well-designed and statistically evaluated clinical trials incorporating 
appropriate animal numbers and control treatments.
The ability of clinicians to accurately assess the efficacy of thera-
pies in practice is known to be highly unreliable, as demonstrated by 
the many examples of therapies thought to have been effective by 
the doctors that used them that were later proven ineffective or even 
actively harmful (Doust and Del Mar 2004, Prasad and Cifu 2016), 
and the high incidence of misdiagnosis – and hence mistreatment 
– revealed by autopsy studies (Shojania and others 2003). There are 
many causes of the unreliability of clinicians’ assessment of treatment 
efficacy, and many of them are cognitive in nature, the result of biases 
that are inherent to human perception and reasoning (Kahneman 
2012, Matute and others 2015) and that influence clinicians’ judge-
ments in their everyday work (Croskerry 2003, Gay 2006, Hartman 
2009, McKenzie 2014, Canfield and others 2016, Saposnik and others 
2016). The degree of reliability of judgment varies with the type of 
therapy; if a drug’s response occurs very quickly after administration, 
is very large, very repeatable and markedly different to the animal’s 
natural variation over time, it is easy for the clinician to make accurate 
judgments on efficacy. Thus, practitioners can judge the effectiveness 
of an intravenous general anaesthetic, such as alfaxalone or propo-
fol, very clearly. Within seconds of administration, the animal’s state 
changes from conscious and responsive to unconscious and unrespon-
sive, in a highly repeatable way that would not occur if the animal 
had not been given the anaesthetic. Assessing the response of a dog 
in severe acute pain to an injection of a strong analgesic, such as mor-
phine, is also generally reliable, although the response is slower and 
less readily observed. However, certainty declines as the time to, size 
of, and repeatability of a drug’s effect decreases, and as the animals’ 
variation over time in the relevant characteristics increases. Thus, it 
can be difficult to assess the effect of, say, a nutraceutical joint supple-
ment on a dog’s signs of arthritis six weeks after commencing dosing. 
In the presence of uncertainty about treatment benefits resulting 
from the fact that they are superimposed on natural variation of the 
animals’ signs – and most illnesses will improve because of natural 
healing mechanisms – various psychological biases result in clinicians 
tending to over-estimate the effects of the treatments they have given. 
There are many such biases (Rudolf 1938, Pinto 2001, Gay 2006, 
Kahneman 2012, McKenzie 2014, Matute and others 2015, Canfield 
and others 2016, Saposnik and others 2016); a particularly important 
example is the post-hoc ergo propter hoc error, where an expected 
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change after giving a medicine is attributed to the medicine, whether 
or not the change was actually induced by that medicine. It is because 
of the inherent uncertainties in assessing the response to treatments, 
and the psychological biases that can mislead physicians in judging 
their effectiveness, that randomised, blinded, controlled clinical trials 
have been developed; these can largely, although often not perfectly, 
remove the effect of errors in judgment. Unfortunately, many prac-
titioners are largely unaware of the many psychological biases that 
influence their everyday clinical judgments – a greater awareness of 
such biases would improve the practice of both veterinary and human 
medicine, whether conventional or alternative (Croskerry 2003, 2013, 
Gay 2006, McKenzie 2014, Canfield and others 2016).
The design, conduct and reporting of clinical trials is also subject 
to a number of biases, in particular to confirmation bias, ascertainment 
bias, selection bias and publication bias (Easterbrook and others 1991, 
Stern and Simes 1997, Ioannidis 1998, 2005b, 2014, Ioannidis and 
others 2001, Bekelman and others 2003, Lexchin and others 2003, 
Chan and others 2004, Jadad and Enkin 2007, Viera and Bangdiwala 
2007, McGauran and others 2010, Sargeant and others 2010, 
Hróbjartsson and others 2012, Kahan and others 2015, Ahn and oth-
ers 2017). For clinical trials, the ideal features (rarely achieved in veteri-
nary medicine) are: independent investigators; blinding of the person 
administering the product and the individuals making the response 
assessment as well as those analysing the data, and also the patient in 
human trials; a sufficient number of treated patients (often requiring 
a power calculation); incorporation of a positive control (alternative 
drug usually of the same group) and/or a negative control (usually 
placebo-treated); allocation of treatments to groups on a truly random 
basis; appropriate use of statistics; accurate and detailed reporting of 
the methods and results; high-quality peer review; and replication of 
the trial by independent investigators. Replication of clinical trials is 
particularly uncommon in veterinary medicine. Objective guidelines 
exist for assessing randomised controlled trials (RCTs) with regard 
to these factors (Schulz and others 2010, Higgins and Green 2011, 
Sargeant and O’Connor 2014). Two further essential features of the 
ideal clinical trial are that: the trial design, and especially the intended 
primary and secondary outcome measures, be published before con-
ducting the trial (which helps to prevent inappropriate post-hoc statis-
tical analysis); and the trial results be published regardless of the find-
ings. Major deficiencies in clinical trials in these two regards are being 
addressed by the AllTrials (2014) and VetAllTrials (2015) initiatives. It 
has been shown that RCTs carried out by investigators with financial 
conflict of interest produce more positive results than trials carried out 
by independent investigators (Bekelman and others 2003, Lexchin 
and others 2003, Ahn and others 2017). All of these considerations 
apply equally to the assessment of clinical efficacy or effectiveness of 
drug and homeopathic products. 
These ideals are far from always achieved in human RCTs of con-
ventional medicines (Ioannidis 2005b, 2014, Prasad and Cifu 2015), 
much less frequently in RCTs of homeopathy, and rarely in veterinary 
RCTs. Di Girolamo and Meursinge Reynders (2016) reviewed the 
effectiveness-of-intervention studies in five leading veterinary journals 
and five leading medical journals for the year 2013. Median numbers 
were 26 and 465, respectively, the veterinary studies were smaller and 
only 2 per cent of veterinary RCTs v 77 per cent of human RCTs 
reported power calculations, primary outcomes, random sequence 
generation, allocation concealment and estimation methods. One 
reason for these differences is cost; pharmaceutical companies must 
necessarily make a profit and these are generally much smaller on 
veterinary than on human medicines. Another factor is animal wel-
fare. Can we, the best scientific approaches notwithstanding, ethically 
justify a placebo-controlled trial in calves with acute pneumonia or 
dogs with severe osteoarthritis? These issues are not easily addressed. 
Trials with negative results (however useful they might be) are 
less likely to be published than those with positive findings, not least 
because of journal editors’ interest in preserving or enhancing their 
impact factors (Easterbrook and others 1991, Stern and Simes 1997, 
Ioannidis 1998, Smith 2006). Independent replication of clinical trials 
is important in establishing efficacy (Ioannidis 2005a, 2014, Anon 
2013, Prasad and Cifu 2015). It permits a check on whether the initial 
study might have had false-positive or false-negative results, or shown 
an unrepeatable effect size. Ioannidis (2005a) reported on 49 human 
clinical studies. Thirty-four reported a significant positive effect, but 
when later retested the results were negative in seven cases and the 
effect sizes smaller than in the initial report in seven more. The rea-
sons might include improved study design in the replication studies 
reducing false-positive findings of the initial studies. Random ‘noise’ 
– chance variation – will result in false positives one occasion in 20 
at the P=0.05 level of statistical significance. If a study measures 10 
variables, chance alone will give a 50 per cent probability that one of 
them will be ‘statistically significant’ unless statistical techniques are 
adopted to adjust for that fact – which is not always done. However, 
most false positives are likely due to other factors, particularly failure 
to fully control for confounding factors – as mentioned above – such 
as biases and the natural course of the diseases.
For the above reasons, doctors and veterinarians should always be 
vigilant and constructively critical in making assessments both on the 
basis of their everyday clinical experience and of clinical trial findings. 
The assessment difficulties are likely to be greater when the end-point 
measurements of efficacy are nebulous and/or subjective rather than 
clear and/or objective, and so the risk of erroneously ascribing a spe-
cific treatment effect to an actually ineffective medicine will be higher. 
Homeopathy is most frequently used to treat chronic conditions 
with fluctuating signs, or acute, self-limiting conditions (Jacobs and 
others 1998, Mathie and others 2007, 2010). These are precisely those 
conditions for which assessment of treatment responses is most diffi-
cult and prone to error because of the natural history of the disease and 
subjective biases, and so it is particularly important that responses to 
therapy are not based purely on subjective assessments and anecdotal 
experiences of veterinarians (Mathie 2007, 2010), or on the results 
of poorly designed and conducted clinical trials, but rather on the 
results of well-designed and conducted RCTs. This is well illustrated 
by the example of homeopathic treatment of feline hyperthyroidism. 
Two prospective ‘outcome studies’ (Mathie and others 2007, 2010) – 
uncontrolled reports of how well practitioners and or clients believed 
hyperthyroid cats responded to treatment – and one case series of four 
hyperthyroid cats (Chapman 2011), each suggested that homeopa-
thy is an effective treatment for hyperthyroidism. However, a well-
designed, double-blinded RCT showed that individualised homeopa-
thy had no effect on hyperthyroidism, as assessed by blood thyroid 
hormone level, heart rate and weight after 21 days, whereas standard 
methimazole treatment was effective (Bodey and others 2017).
Peer-reviewed clinical trials and systematic reviews
As discussed above, for clinical trials in people and animals, there exist 
widely accepted (but not always applied) standards, procedures and 
guidelines on study design and conduct and the statistical evaluation of 
data generated, with recommended features including randomisation, 
blinding, positive and/or negative (placebo) controls and sufficient 
number of animals. These general principles are explicated in detail in 
various published guidelines for designing and/or assessing RCTs (for 
example, Schulz and others 2010, Higgins and Green 2011, Sargeant 
and O’Connor 2014). Systematic reviews use this type of objective 
methodology to formally assess the design, conduct and reporting of 
published controlled clinical trials to minimise the effects of bias, and 
there are formal, objective protocols and guidelines for conducting 
systematic reviews and meta-analyses (see Higgins and Green 2011, 
Zoonoses and Public Health 2014, PRISMA 2017). Clinical trials in 
both human and veterinary medicine, which have been objectively 
evaluated as meeting high standards and thus ensuring high-quality 
evidence, provide a huge body of evidence, which inevitably is not 
universally complimentary to drug-based products and extremely 
rarely supports a positive outcome from homeopathic trials. 
A means of boosting animal/patient numbers is to take a number 
of trials of sufficient quality of design and conduct, and analyse the 
composite of those trials – a meta-analysis. There are several objec-
tive methods for assessing the quality of meta-analyses and systematic 
reviews. This is one major function of the Cochrane Collaboration 
(www.cochrane.org/), an international not-for-profit organisation 
of collaborating medical professionals tasked with determining the 
effectiveness of treatments, which produces systematic summaries of 
research literature in healthcare. 
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For homeopathic products used in people, there is a large base of 
peer-reviewed published clinical trials, and several reviews thereof 
(Linde and others 1997, Cucherat and others 2000, Jonas and others 
2003, Shang and others 2005, Milazzo and others 2006, Ernst 2010, 
Mathie and others 2014, 2017). Shang and others’ (2005) meta-anal-
ysis assessed every clinical trial conducted in people published up to 
that time investigating the efficacy of homeopathy. Poor-quality trials 
were excluded to provide a demanding but fair test. Shang and others 
(2005) found a small positive effect of homeopathic treatments over 
placebo, much smaller than the positive effect of conventional treat-
ments over placebo. Given the difficulty of completely removing bias 
in clinical trials, and the fact that even the best-quality trials were not 
ideal, their finding was consistent with residual bias affecting the trial 
results and the authors, therefore, concluded that the apparent ben-
efits of homeopathy were compatible with placebo effects. However, 
the data reported by Shang and others (2005), in and of itself, does 
not allow the conclusion to be drawn that the small positive effect 
reported was not a specific effect of homeopathic products.
As pointed out by Hektoen (2005) ‘animal studies may…. be more 
useful than human studies in determining whether homeopathic 
remedies have specific effects in comparison with a placebo’. Mathie 
and others (2012) collated RCTs of veterinary homeopathy, and iden-
tified 38 substantive peer reviewed articles suitable for future review. 
Mathie and Clausen (2014) carried out the first systematic review of 
RCTs of veterinary homeopathy compared with placebo (18 RCTs, 
12 therapy and six prophylaxis) quantifying effect size. Only one trial 
was free of vested interest (eight were unclear) and risk of bias was 
high in 11, low in one and unclear in six. They concluded; ‘mixed 
findings from the only two placebo-controlled RCTs that had suit-
ably reliable evidence precluded generalisable conclusions about the 
efficacy of any particular homeopathic medicine or the impact of indi-
vidualised homeopathic intervention on any given medical condition 
in animals’. Mathie and others (2014) also carried out a systematic 
review and meta-analysis of randomised placebo-controlled trials of 
individualised homeopathic treatments in humans. The conclusion 
was that they ‘may have small, specific treatment effects ... the low or 
unclear overall quality of the evidence prompts caution in interpreting 
the findings. New high quality RCT research is necessary to enable 
more decisive interpretation’.
Thus, on the basis of evidence from RCTs, meta-analyses and sys-
tematic reviews alone, the small positive effects reported in people and 
animals could be the result either of specific effects of homeopathy or 
residual bias not fully controlled for in the trials (Cucherat and oth-
ers 2000, Shang and others 2005, Mathie and Clausen 2014, 2015a, 
Mathie and others 2014, 2017). In light of the considerations discussed 
in this review and part 1 (Lees and others 2017), on: the potential for 
the natural history of diseases, placebo effects and subjective biases to 
yield artifactual positive results; the difficulties in assessing evidence 
and, particularly, of performing RCTs to ideal standards; and the 
implausibility on theoretical grounds of homeopathic remedies hav-
ing any specific effect, it is overwhelmingly likely that small effects 
observed in the RCTs and systematic reviews are the result of residual 
bias in the trials. In contrast, the clinical effects claimed in veterinary 
practice by homeopaths are often large (Mathie and others 2007, 2010).
Mathie and Clausen (2015b) conducted another systematic 
review of RCTs of veterinary homeopathy, in which the control group 
received an intervention (active controls) rather than a placebo. They 
used Cochrane methods to assess risk of bias and derive effect size in 
14 treatment and six prophylaxis studies. They concluded that, due 
to the poor reliability of the data – no trial had sufficiently low risk of 
bias to be judged reliable – the trials did ‘not provide useful insight into 
the effectiveness of homeopathy in animals’. 
Doehring and Sundrum (2016) performed a review of trials of 
homeopathy used for the treatment of infectious diseases or growth 
promotion in farm animals. Of 48 studies meeting their inclusion cri-
teria, 15 were doctoral theses and 33 were published in peer-reviewed 
journals, of which 18 were in journals dedicated to homeopathy or 
alternative medicine and 15 in veterinary journals. Their literature 
review specifically included a wide range of trial designs, including 
RCTs – eight of which had been excluded from Mathie and Clausen’s 
(2014) systematic review of veterinary homeopathy RCTs for not con-
stituting reliable evidence, and lower-quality controlled studies that 
were unblinded and/or unrandomised and/or with a control group 
that was not placebo-treated, and some observational studies that had 
no control group. For these reasons, there was substantial potential for 
non-specific effects including bias, and many of the trials with find-
ings positive for homeopathy cannot be taken as good-quality evi-
dence that homeopathy is effective. Doehring and Sundrum (2016) 
found that the trials better designed to reduce non-specific effects pro-
duced results less positive for homeopathy. They also found that trials 
published in journals devoted to homeopathy or alternative medicine 
were much more likely to be positive for homeopathy than trials pub-
lished in journals with a broader focus on veterinary medicine (15 
of 18 trials v six of 18 trials), indicating publication bias. The trials 
that produced results positive for homeopathy included a very heter-
ogenous range of diseases, remedies and circumstances, but not one of 
them had been replicated. Doehring and Sundrum (2016) concluded 
there was insufficient evidence to recommend that homeopathy be 
used to replace or reduce antibiotics in the treatment of farm livestock.
Ethical and negative aspects of pharmacology and 
homeopathy
As discussed by Jacobs and others (1998), homeopathy in people is 
used most frequently in chronic and acute, self-limiting conditions. 
Likewise, in small animal practice, there is a high prevalence of chronic 
diseases, including allergies and joint diseases, for which drug-based 
therapeutics offers real but often only palliative care. This can stimu-
late pet owners to search for and even insist on alternative medical 
treatments (Hektoen and others 2004, Hektoen 2005). In farm animal 
medicine, homeopathy has found favour with some organic farmers, 
who rightly perceive the downsides of conventional therapeutics, 
while being reluctant to acknowledge the upsides. The disadvantages 
of drug-based therapeutics are, in some cases: failure to achieve ‘cure’ 
(ie, less than 100 per cent efficacy); toxicity to the treated animal; trace 
amounts of drugs and their metabolites in meat and milk; and emer-
gence and spread of antimicrobial and anthelmintic resistance, not 
only compromising the success of animal therapy but involving spread 
of resistance factors into the environment (Toutain and others 2016a). 
Hovi and Roderick (1999) reported that homeopathy was the 
main alternative to antibiotic therapy on UK organic farms, account-
ing for 50 per cent of mastitis treatments. The use of homeopathic 
products may be ideologically based (a preference for ‘natural’ prod-
ucts or a dislike of drugs as ‘chemicals’), a result of the above men-
tioned disadvantages of conventional therapies, and/or economically 
based, using inexpensive homeopathic products and also no require-
ment to adhere to milk and meat withholding periods.
The vast majority of medical scientists, doctors and clinical veteri-
narians support the judicious use of drug-based products and vaccines 
as the mainstay of veterinary therapeutics. However, cultural and 
social differences occur between countries, and complementary thera-
pies, including homeopathy, are more extensively accepted and prac-
tised in, for example, France, Italy, Germany and India than in the UK. 
Pharmacology
Despite all the welfare benefits of safe anaesthesia, control of pain, 
effective prevention and cure of diseases caused by microorganisms, hel-
minths and ectoparasites and many other benefits, there are significant 
downsides to the use of drug-based veterinary products. There will be 
many occasions when the drugs themselves are ineffective or effective 
suboptimally. Many drugs are being used by doctors and veterinarians 
despite an insufficient evidence base to prove their efficacy, some of 
which will go on to be proven ineffective (Prasad and Cifu 2015). There 
are side effects for virtually all drugs, which may be life threatening. Side 
effects may be idiosyncratic (rare but marked toxicity with clinically 
recommended dosage) but more usually are dose-related. Side effects 
of conventional medicines arise from biochemical and physiological 
mechanisms, and many drugs have characterised toxicological thresh-
olds and dose/response relationships in the same way as they have phar-
macological thresholds and dose/response relationships.
A negative aspect of current global concern is the emergence of 
resistance to antimicrobial drugs. Relative to people, this is less of a 
concern in terms of effective treatment of microbial disease in ani-
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mals, for which many drugs have retained a high level of efficacy, 
but a major concern is the impact on the environmental resistome, 
through the extensive use of antimicrobial drugs, in particular in farm 
animal medicine. The significance of this as a potentially major pub-
lic health issue is increasingly recognised (Toutain and others 2016a). 
For therapies of all classes, there is the universal dimension of clients’ 
expectations that they always should be administered tablets or an 
injection when they visit the veterinarian or doctor. Carefully man-
aging this expectation would reduce the unnecessary dispensing of 
drugs, most important for antimicrobial drugs, thereby reducing the 
global problem of antimicrobial resistance.
Homeopathy
Homeopaths argue that, at least homeopathy does no harm. This is 
questionable. Although it is unlikely that most homeopathic remedies 
contain substances that could have a specific toxic effect. The World 
Health Organization (2009) advises ‘there are a few aspects of the 
production of homeopathic medicines that could constitute potential 
safety hazards. Firstly, not all homeopathic medicines are administered 
at a high dilution. Sometimes, a homeopathic medicine made from 
source material, such as a mother tincture, is administered in the most 
concentrated form… Secondly, homeopathic medicines are made from 
a wide range of natural or synthetic sources including fungi, bacteria, 
viruses and plant parasites… Some of these source materials constitute 
potential safety hazards, even at high dilutions’. 
In human patients, placebo effects can be of genuine value, as dis-
cussed in part 1 of this review (Lees and others 2017). However, in vet-
erinary medicine it will be very rare – unless specifically organised by 
prior conditioning of the animal – that circumstances will be such that a 
genuine placebo effect can be of benefit. In human medicine also, there 
can be a counselling/psychotherapeutic aspect to homeopathic consults 
that can be of benefit to the patient, and in veterinary medicine such 
consults can be of benefit to animal owners, but not directly to the ani-
mals. Indeed, placebo effects engendered in owners – known as ‘car-
egiver placebo effects’ (Conzemius and Evans 2012, Gruen and others 
2014, 2017) – can actually be detrimental to their animals because the 
owners perceive an improvement that may not be present. Probably the 
most harmful aspects of homeopathy are the delay in treatment, or the 
withholding of conventional treatments completely, when ineffective 
homeopathic remedies are given to animals that may be suffering, in 
place of effective conventional treatments, as established by scientifi-
cally demanding regulatory requirements and/or published clinical tri-
als. Similarly, use of an ineffective homeopathic preparation, in place of 
effective conventional vaccination, and withholding other prophylactic 
treatments such as wormers, may be harmful to animal welfare. Use of 
an ineffective treatment in these circumstances is unethical, particularly 
because animals, like young children, have no voice in the treatment 
they receive. Moreover, clients, including sometimes desperate owners, 
should not be offered false hope through ineffective products. It is most 
unlikely that a veterinarian prescribing a homeopathic product will 
inform the client that it is lacking in specific efficacy. For clients who 
insist on homeopathic treatments, even if fully informed, in veterinary 
medicine, it is questionable whether client demand should take prec-
edence in those cases where there are clear animal welfare issues.
Homeopaths commonly recommend that drug-based products 
should actively be avoided. The Academy of Veterinary Homeopathy 
Standards of Practice (2017) states, ‘Concurrent treatment with many 
drugs, herbs, acupuncture and other types of intervention can reduce 
the effectiveness of homeopathic medicines … only those medicines 
that are homeopathic to the patient’s condition should be administered 
… Concurrent drugs, herbs, and electromagnetic applications should 
be avoided, when possible, to prevent the possibility of interfering 
effects on the life force …’ It is common for veterinary homeopaths to 
claim that vaccination is harmful and that commonly used veterinary 
medicines interfere with homeopathic treatment (for example, Gregory 
2008, 2013b); ‘it is also well known among homeopaths that the action 
of homeopathic remedies is severely reduced by concurrent administra-
tion of NSAIDs or indeed any other anti-inflammatory agents, such as 
corticosteroids or ciclosporin’ (Gregory 2013b).
Another negative aspect of homeopathy is that, when offered 
by veterinarians, it devalues conventional veterinary qualifications 
through the use of ineffective and irrational treatments – failing to 
differentiate veterinary surgeons from unlicensed healers and so 
undermining confidence in mainstream medicine (Chambers 2013). 
In veterinary medicine, homeopathy is practised by a small minority 
of practitioners, with postnominals granted by homeopathic organisa-
tions, but used alongside recognised veterinary qualifications, without 
any distinction being made between the qualifications that are recog-
nised by veterinary regulators and those that are not.
For discussion of the ethics of the practice of homeopathy on 
human patients, see Shaw (2010) and Smith (2012). Among other 
problems, both argue that the practice of homeopathy by doctors is 
a waste of medical resources and that, when doctors practice home-
opathy but fail to acknowledge the placebo effect as the principal 
basis for efficacy, they are being economical with the truth, providing 
homeopathy with unwarranted credence, and weakening support for 
science-based and evidence-based medicine. These factors all apply to 
veterinary practice as well. However, in human medicine there are, at 
least, recognised placebo effects, and the counselling/psychotherapy 
aspects of homeopathic consultations, that may be of value to those 
patients who seek out homeopathy. In contrast, in veterinary medi-
cine, these effects are of no benefit to animals, as veterinary homeo-
paths are effectively treating owners, not animals, when prescribing 
ineffective remedies for the owner’s animals.
Acceptance of homeopathy
The doctor and science writer Goldacre (2008) wrote, in his book 
Bad Science, ‘homeopathy is perhaps the paradigmatic example of an 
alternative therapy: it claims the authority of a rich historical heritage, 
but its history is routinely rewritten for the PR needs of a contemporary 
market; it has an elaborate and sciencey-sounding framework for how 
it works, without scientific evidence to demonstrate its veracity; and 
its proponents are quite clear that the pills will make you better, when 
in fact they have been thoroughly researched, with innumerable trials, 
and have been found to perform no better than placebo’.
The practice of homeopathy confronts us with two clear, mutu-
ally exclusive hypotheses. One is that homeopathic remedies are 
genuinely effective. However, that hypothesis is extremely implau-
sible, for all the reasons discussed in this two-part review. The other 
hypothesis is that homeopathy has no effect beyond placebo effects 
and that homeopaths’ judgement of the efficacy of their remedies is 
incorrect. This is a simple and highly plausible hypothesis, for all the 
reasons discussed in this two-part review, which appears consistent 
with all available evidence.
Open discussion, debate and criticism of all medical treatments 
must be encouraged. Opinions based on anecdote and experience are 
unreliable. Conclusions on efficacy and safety will have most value 
when they are based on sound science and objective weighing of all 
available evidence. Science is bottom up and ‘evolutionary’, building 
upon previously established facts using the ‘parsimony principle’ – the 
simplest explanation possible. Homeopathy, on the other hand, is top 
down and faith-based; governed by arbitrary laws, invented by the 
founder, Hahnemann, which are immutable. As such, homeopathy is 
not just unscientific, it is a genuinely mystical belief system.
There are clear differences between the laws of homeopathy and 
the scientifically determined laws of nature. Laws of nature are not 
arbitrary; they are based on formal observation of phenomena, have 
been thoroughly tested and for most of them the underlying mecha-
nisms have been elucidated. No law of nature is inconsistent with 
physics, chemistry and biology, and many are related to each other in 
ways that show them to be part of the same overall natural system. In 
contrast, the three laws governing homeopathic remedies (‘like-cures-
like’, dilution/infinitessimals and succussion) are arbitrary. They have 
not been subjected to rigorous testing, there is no known underly-
ing mechanism(s), and the Law of Infinitessimals in particular is not 
only arbitrary, but explicitly contrary to the scientific understand-
ing of physics, chemistry and biology. Furthermore, the three laws 
of homeopathy have no apparent relationship to each other. Thus, 
there appears to be no a priori reason why a curative property that 
would be efficacious on the basis of the particular type of ‘like-cures-
like’ favoured by homeopathy should also have stronger effects when 
highly diluted and/or require succussion for its healing effect to be 
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activated. And no a priori reason why potentisation of that curative 
property requires both dilution and succussion.
No theory to explain the alleged specific healing effects of homeo-
pathic remedies is compatible, even marginally, with what is known 
of bodily functions or the properties of disease-causing organisms. 
The unknown ‘curative property’ of homeopathic remedies is super-
natural in that it acts ‘beyond scientific understanding or the laws 
of nature’ (Oxford Dictionaries 2017). Its supernatural properties 
include: it is present throughout most if not all of the physical world 
but is undetectable by science even though it must interact with physi-
cal matter to have the properties attributed to it by homeopaths; it 
increases in potency with increasing dilution; and it can be manipu-
lated by the initiated – trained homeopaths – in order to treat almost 
any of a huge variety of diseases of widely differing aetiologies and 
pathogeneses, without doing harm.
‘Magic’ is commonly defined as ‘the power of apparently influ-
encing events by using mysterious or supernatural forces’ (Oxford 
Dictionaries 2017). In anthropology – the academic study of aspects 
of humans within past and present societies, which field includes 
magical and religious beliefs – ‘magic’ generally refers to ‘beliefs and 
behaviours in which the relationship between an act and its effect is 
not empirically or scientifically verified but, from a Western perspec-
tive, rests on analogy or a mystical connection’ (Moro 2012). Thus, 
‘like-cures-like’ – in the absence of a scientific explanation and resting 
entirely on analogy – is an explicitly magical belief in the ancient 
tradition of sympathetic magic (Fraser 1922). 
The practice of homeopathy by veterinary surgeons is accepted 
by veterinary regulatory bodies around the world, including the Royal 
College of Veterinary Surgeons in the UK (Viner 2016). The issues 
discussed in this article and its companion (Lees and others 2017) raise 
two key questions. First, is it appropriate for veterinary professionals 
to treat animals on the basis of mystical beliefs requiring invocation 
of supernatural forces. It can be argued that doing so diminishes our 
science-based profession as a whole. As expressed by Hektoen (2005), 
‘it is important for the veterinary profession to discuss the question of 
whether veterinarians, as medical professionals, should recommend 
or practise a theory with no scientific basis, and to what extent clients’ 
preferences and motivation for treatment should be acknowledged’. 
Likewise, the Connecticut Veterinary Medical Association (2013) 
advised that ‘the veterinary profession has an obligation to society 
and to our clients to acknowledge the conclusions of science even 
when there is not absolute unanimity within the profession. If we 
wish to retain the trust of the public, upon which our work depends, 
we must demonstrate that our recommendations are based on sound 
science and that we are willing to put the welfare of our patients and 
clients first even when some of our colleagues object’. 
Second, if homeopathic remedies have no specific effect; and it is 
rare that placebo effects exerted through the owner will be beneficial to 
the animal and, more commonly, the placebo effects on the owner will 
be irrelevant or even harmful to the animal; and use of homeopathic 
remedies may delay or prevent use of proven-effective conventional 
treatments in ill animals, is use of homeopathy by veterinary surgeons 
acceptable? If it is, the principle of informed consent implies that the 
prescribing veterinary surgeon should inform clients that homeopath-
ic products have no benefit beyond non-specific effects and to fully 
inform clients of the nature of placebo effects and that they will typical-
ly have no effect on their animal(s) (Whiting 2012). It would, moreover, 
be ethical to insist on an immediate recourse to a proven conventional 
therapy when any form of pain or other suffering is diagnosed. It is 
not clear if this manner of proceeding is generally observed by homeo-
pathic veterinary surgeons at present, and it cannot be doubted that the 
use of ineffective practices by veterinary surgeons, in the sincere belief 
that they are effective, is capable of compromising animal welfare.
Conclusions
Homeopathy appears to be one of many examples from the history 
of medicine, of therapies, conventional and otherwise, which were 
thought to be effective but were later proved to be ineffective or even 
harmful. One doctor, Samuel Hahnemann, working more than 200 
years ago, at a time preceding modern science and medicine, proposed 
a vitalist system of therapy that has persisted to the modern day 
despite being incompatible with the modern scientific understanding 
of the world, and despite the failure of high-quality clinical trials 
to demonstrate efficacy for even one medical condition (House of 
Commons Science and Technology Committee 2010, Australian 
Government 2015; see supplemental material for this article). The 
homeopathic curative property is not detectable by scientific methods 
and, although homeopaths report that their remedies are effective 
when used in their practice, efficacy beyond placebo is not apparent 
in well-controlled clinical trials, which eliminate biases and other 
non-specific effects. In human medicine, there may be a place for the 
counselling/psychotherapeutic aspects of homeopathic consults and 
the placebo effects generated by homeopathic products in patients 
who believe in such treatments, but in veterinary medicine these 
factors are unlikely to benefit patients, and the use of homeopathic 
products in veterinary medicine is contrary to best evidence, irrational, 
and inconsistent with current scientific and medical knowledge 
(Chambers 2016, Whitehead and others 2016). 
The pharmacological basis of therapeutics is, in virtually every 
respect, the opposite of homeopathy. In the great majority of cases 
it is based on increased effect provided by increased dose or concen-
tration up to a ceiling, the maximum attainable response. Doses are 
determined by the application of data on each drug’s pharmacody-
namic and pharmacokinetic properties, established on a species basis. 
Additionally, increasingly recognised is the need sometimes to adapt 
dose not only for bodyweight but also for disease severity, condition 
of animal, as well as age and breed differences in pharmacodynamics 
and pharmacokinetics. Drug-based therapeutics emerged by evolu-
tionary processes from Materia Medica, which it has supplanted, and 
it will continue to evolve with advances in clinical and non-clinical 
sciences. As reviewed in this article, there are many disadvantages to 
the use of drug-based products in veterinary medicine. However, their 
benefits and their side effects are based on principles compatible with 
modern scientific knowledge. They are subject to rigorous evaluation 
for quality, safety and efficacy by regulatory authorities (unlike home-
opathic remedies; see supplemental material for this article). They 
have contributed greatly to animal welfare and the relief of suffering.
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